Antimyeloma activity of NK012, a micelle-forming macromolecular prodrug of SN-38, in an orthotopic model-Reference-Cited by-同舟云学术

Antimyeloma activity of NK012, a micelle-forming macromolecular prodrug of SN-38, in an orthotopic model

Published:2013-07-16 Issue:1 Volume:134 Page:218-223
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Miyazaki Osamu¹,Sekine Keiko¹,Nakajima Naoko¹,Ichimura Eiji¹,Ebara Keiko¹,Nagai Daichi¹,Onda Takeshi¹,Miyakawa Yoshitaka²,Okamoto Kazuya¹,Morino Tomio¹

Affiliation:

1. Pharmaceutical Research Laboratories, Nippon Kayaku Co., Ltd.; Tokyo; Japan

2. Division of Hematology; Department of Medicine; Keio University; Tokyo; Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Multiple myeloma;Palumbo;N Engl J Med,2011

2. Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs;Morabito;Eur J Haematol,2010

3. Proteasome inhibitors in multiple myeloma: 10 years later;Moreau;Blood,2012

4. Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors;Koizumi;Cancer Res,2006

5. CPT-11 converting enzyme from rat serum: purification and some properties;Tsuji;J Pharmacobiodyn,1991

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials;Pharmaceutics;2024-08-06

2. Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model;Cancer Immunology, Immunotherapy;2022-11-16

3. Pheophorbide A and SN38 conjugated hyaluronan nanoparticles for photodynamic- and cascadic chemotherapy of cancer stem-like ovarian cancer;Carbohydrate Polymers;2022-08

4. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model;Cellular & Molecular Immunology;2021-05-12

5. Advanced drug delivery systems in blood cancer;Advanced Drug Delivery Systems in the Management of Cancer;2021